导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -3.14% | 669/1050 |
| 近一周 | -2.91% | 910/1104 |
| 近一月 | -5.27% | 794/1103 |
| 近一季 | -9.50% | 681/1092 |
| 近半年 | -2.96% | 554/1070 |
| 近一年 | -1.19% | 614/1018 |
| 近两年 | 52.28% | 500/926 |
| 近三年 | -8.33% | 730/834 |
| 成立以来 | 112.10% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-4.45% 780/1070 |
13.92% 471/1101 |
- - |
- - |
| 2025 | 23.34% 612/1065 |
4.79% 425/1014 |
-2.04% 846/1038 |
24.82% 448/1050 |
-3.74% 649/1065 |
| 2024 | -1.26% 614/1011 |
-5.36% 587/960 |
-7.41% 764/983 |
23.37% 35/991 |
-8.65% 852/1011 |
| 2023 | -22.26% 733/952 |
1.15% 563/880 |
-2.76% 358/895 |
-1.13% 121/915 |
-20.06% 915/952 |
| 2022 | -8.48% 68/867 |
0.28% 7/773 |
-2.35% 731/806 |
-6.13% 85/845 |
-0.44% 462/867 |
| 2021 | 31.06% 65/740 |
-6.97% 417/580 |
11.09% 327/659 |
22.18% 13/704 |
3.79% 271/740 |
| 2020 | 42.10% 288/554 |
-0.08% 162/419 |
14.52% 363/466 |
5.15% 362/517 |
18.09% 154/554 |
| 2019 | 73.17% 24/410 |
35.86% 124/1146 |
- 332/1228 |
11.95% 81/390 |
13.86% 74/410 |
| 2018 | -29.26% 205/349 |
- - |
-9.66% 466/990 |
-5.29% 475/1000 |
-11.06% 395/1080 |
| 2017 | 17.90% 88/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 工银国家战略股票 VS. 东吴新产业精选股票A(580008) |